NCT00006457View on ClinicalTrials.gov

Oltipraz in the Prevention of Lung Cancer in People Who Smoke

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

August 31, 2000

Primary Completion Date

April 30, 2004

Study Completion Date

April 30, 2004

Conditions
Lung Cancer
Interventions
DRUG

oltipraz

Trial Locations (2)

27710

Duke Comprehensive Cancer Center, Durham

60611-3013

Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Northwestern University

OTHER

NCT00006457 - Oltipraz in the Prevention of Lung Cancer in People Who Smoke | Biotech Hunter | Biotech Hunter